CR1 and non-small cell lung carcinoma: In the context of pulmonary malignancies, particularly non-small cell lung cancer (NSCLC), circulating concentrations of Cripto-1 (CR-1) and vascular endothelial growth factor (VEGF) have been shown to be markedly elevated relative to those observed in healthy control cohorts.